Understanding Macular Degeneration
What Macular Degeneration Does to Your Eyes
AMD affects the macula, a small but vital area at the center of the retina (the light-sensitive tissue at the back of your eye). The macula is responsible for the sharp, focused vision you rely on every day for reading, driving, and recognizing faces. Understanding how AMD works helps you take the right steps to protect what matters most.
Over time, AMD causes the cells of the macula to break down, leading to a gradual loss of central vision. The damage can be slow and subtle at first, which is why many people do not notice it until it has already progressed. AMD is the leading cause of irreversible central vision loss in adults over 50 in the United States.
The dry form of AMD is the most common type, accounting for the large majority of cases. In dry AMD, tiny yellow deposits called drusen accumulate beneath the retina. Eye doctors classify dry AMD in three stages: early, intermediate, and late. Early AMD produces no symptoms and involves small drusen. Intermediate AMD may cause mild blurring or difficulty in low light. Late dry AMD, also called geographic atrophy, involves significant loss of central vision as retinal cells gradually die off. Many people remain in the early stage for years without noticing any change in their vision.
Wet AMD develops when abnormal blood vessels grow beneath the retina and leak blood or fluid. This form is less common than dry AMD, but it causes vision loss that is faster and more severe. A portion of people with dry AMD will eventually convert to wet AMD over time. If you suddenly notice that straight lines look wavy or bent, or if a new dark spot appears in the center of your vision, contact your eye doctor right away. These symptoms may signal wet AMD and require same-day evaluation.
AMD damages central vision but leaves peripheral (side) vision intact. This means people with AMD can still move around their home, recognize large objects, and maintain a meaningful level of independence. AMD alone does not cause complete blindness, though advanced stages can make everyday tasks like reading and driving very difficult.
Who Gets AMD and Why
AMD develops from a combination of aging, genetics, and lifestyle factors. Knowing your personal risk helps you and your eye doctor decide how often you need monitoring and what steps to take to reduce your chances of progression.
Age is the most significant risk factor for AMD. The condition becomes much more common after age 50 and the risk continues to rise with each passing decade. Family history also plays a meaningful role. Having a parent or sibling with AMD raises your risk several times above average. Specific genes, including CFH and ARMS2/HTRA1, are linked to a significant portion of AMD cases. People of Northern European descent tend to face a higher risk than other populations.
Smoking is the single most important modifiable risk factor for AMD. Smokers face a substantially higher risk of progressing to advanced or wet AMD compared to non-smokers, and the risk grows with years of use. Quitting at any age lowers your risk over time. Other controllable factors include a diet low in leafy greens and fish, physical inactivity, obesity, and uncontrolled high blood pressure. Making positive changes in any of these areas supports your overall eye health alongside medical care.
Early AMD typically causes no noticeable symptoms, which is why routine eye exams are so important. Your eye doctor uses a comprehensive dilated eye exam combined with advanced imaging, such as optical coherence tomography (OCT), to detect drusen and retinal changes before vision loss begins. Annual dilated exams are recommended for adults 60 and older, and earlier if you have risk factors such as family history or smoking. At home, checking an Amsler grid (a simple pattern of lines) with each eye every day can help you catch new distortion between office visits.
Treatment Options for AMD
The right treatment for AMD depends on which type you have and how far it has progressed. Our retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, use the most current approaches available to slow progression, protect vision, and when possible, improve it. No current treatment restores vision that has already been lost, so early detection and consistent monitoring are essential.
For people with intermediate dry AMD, a specific vitamin and mineral formula known as AREDS2 has been shown to reduce the risk of progression to advanced AMD. The AREDS2 formula contains vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin in doses tested in a large clinical trial. These supplements are not the same as standard multivitamins, which do not contain the same concentrations of these nutrients. Your eye doctor will confirm whether your stage of AMD qualifies before recommending them, as they are not appropriate for early AMD or for those without AMD.
For many years, no treatments existed specifically for late dry AMD (geographic atrophy). Two FDA-approved complement inhibitor medications now offer patients the option to slow the growth of geographic atrophy lesions. These medications are given as injections into the eye and represent a significant advancement in care for this previously untreatable stage. Additionally, a photobiomodulation device received FDA authorization for use in non-neovascular AMD. While none of these options reverse existing damage, they can help preserve remaining vision over time. Your retina specialist will determine which approach is appropriate for your situation.
Wet AMD is treated with anti-VEGF (vascular endothelial growth factor) injections delivered directly into the eye by a retina specialist. These medications work by blocking the growth of abnormal blood vessels and stopping fluid leakage. When started promptly, anti-VEGF therapy can stabilize vision and in many cases improve it. Treatment typically involves more frequent visits early on, with intervals adjusted over time based on how your eye responds. Consistent follow-up is critical to maintaining the benefits of treatment.
Checking an Amsler grid each day with each eye separately is one of the most important things AMD patients can do between appointments. The Amsler grid is a simple printed or digital pattern of straight lines with a central dot. If any lines appear wavy, blurry, or missing, or if a blank spot appears, you should contact your eye doctor the same day. These changes may indicate a conversion to wet AMD or a change in the status of existing wet AMD that requires prompt evaluation and treatment.
Living Well with AMD
A diagnosis of AMD does not mean your life stops. With the right support, most people with AMD continue to live actively and independently. Combining medical treatment with healthy habits and practical tools gives you the best chance of preserving what you have.
A Mediterranean-style diet rich in leafy green vegetables, fish, fruits, whole grains, and healthy fats supports macular health and complements medical treatment. Regular physical activity, at least a few times per week, may help reduce the risk of wet AMD conversion over time. Quitting smoking remains one of the most impactful steps any AMD patient can take. These changes do not replace medical treatment, but they are meaningful additions to your overall care plan.
If AMD has reduced your central vision to the point where daily tasks are difficult, low vision rehabilitation can help. Low vision specialists work with you to make the most of the sight you have. Magnifying lenses, high-contrast materials, specialized lighting, and electronic reading aids are just a few of the tools available. Many people with AMD continue reading, cooking, and managing daily life with the right support. Your eye doctor can connect you with rehabilitation services suited to your needs.
Regular follow-up appointments are the cornerstone of AMD management. Most patients need dilated eye exams every six to twelve months, depending on their stage and treatment status. If you have AMD in one eye, your doctor will monitor the other eye closely, since AMD frequently develops in both eyes over time. Attending every scheduled visit and reporting any new symptoms promptly between visits makes a significant difference in long-term outcomes.
Frequently Asked Questions
These are some of the questions our patients ask most often about macular degeneration. If you do not see your question here, our team is glad to answer it at your next visit.
Whether you can drive depends on how much central vision you have remaining. Many people with early or intermediate AMD continue to drive without difficulty. Your eye doctor can measure your visual acuity and visual field and advise you on whether your vision meets the requirements in your state. If your condition changes, it is important to revisit this question with your doctor rather than assuming nothing has shifted.
They are not. AREDS2 supplements contain specific nutrients at doses that were studied in a large, carefully controlled clinical trial designed for AMD. Standard multivitamins do not provide the same concentrations of lutein, zeaxanthin, zinc, and the other components in that formula. Taking a regular multivitamin is not a substitute, and starting AREDS2 supplements without your doctor's guidance is not recommended, since they are only appropriate for certain stages of AMD.
Not always at first, but AMD has a strong tendency to develop in both eyes over time. Many patients are diagnosed in one eye and later develop AMD in the other. This is exactly why your doctor monitors both eyes closely even when only one shows signs of the disease. If you have AMD in one eye, the frequency of your exams and home monitoring becomes even more important for the other.
Anti-VEGF injections target the abnormal blood vessel growth that characterizes wet AMD. The newer complement inhibitor treatments are designed for geographic atrophy, which is advanced dry AMD, a different process involving the gradual loss of retinal cells. Both types of treatment are given as eye injections, but they work through completely different mechanisms and address different stages and types of AMD. Your retina specialist will determine which treatment, if any, is appropriate for your specific diagnosis.
Worsening AMD may appear as increased blurriness in the center of your vision, new distortion in straight lines, a growing blank or dark spot, or difficulty recognizing faces and reading text that previously felt manageable. These changes can develop gradually or suddenly, especially with wet AMD. Daily Amsler grid checks help you catch subtle shifts early. Any new or worsening symptom warrants a call to your eye doctor the same day it is noticed rather than waiting for your next scheduled appointment.
Researchers are actively studying gene therapy and stem cell-based treatments for AMD, and early results are promising. However, as of now, none of these approaches are commercially available or part of standard clinical practice. Patients who are interested in experimental options may want to ask their retina specialist about clinical trial eligibility. For currently available care, the treatments described in this guide represent the most up-to-date options in use today.
Schedule Your AMD Evaluation at Rhode Island Eye Institute
Early detection and consistent care give you the best opportunity to preserve your central vision over time. Our retina specialists at Rhode Island Eye Institute bring subspecialty expertise, advanced diagnostic technology, and genuine commitment to every patient we see. If you are over 50, have a family history of AMD, or have noticed any changes in your central vision, we encourage you to schedule a comprehensive dilated eye exam with our team. We are here to support your vision at every stage.